{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T10:06:31Z","timestamp":1779098791385,"version":"3.51.4"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"JSPS KAKENHI","award":["JP26861479"],"award-info":[{"award-number":["JP26861479"]}]},{"name":"JSPS KAKENHI","award":["JP16K07076"],"award-info":[{"award-number":["JP16K07076"]}]},{"name":"JSPS KAKENHI","award":["16K20341"],"award-info":[{"award-number":["16K20341"]}]},{"name":"JSPS KAKENHI","award":["JP16K11308"],"award-info":[{"award-number":["JP16K11308"]}]},{"name":"JSPS KAKENHI","award":["JP16K08635"],"award-info":[{"award-number":["JP16K08635"]}]},{"name":"JSPS KAKENHI","award":["JP15H04999"],"award-info":[{"award-number":["JP15H04999"]}]},{"DOI":"10.13039\/100007449","name":"Takeda Science Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007449","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience Letters"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.neulet.2016.12.057","type":"journal-article","created":{"date-parts":[[2016,12,28]],"date-time":"2016-12-28T19:31:26Z","timestamp":1482953486000},"page":"82-87","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Valproic acid and ASK1 deficiency ameliorate optic neuritis and neurodegeneration in an animal model of multiple sclerosis"],"prefix":"10.1016","volume":"639","author":[{"given":"Yuriko","family":"Azuchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsuko","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoli","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Goichi","family":"Akiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiko","family":"Noro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chikako","family":"Harada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsuko","family":"Nishigaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiko","family":"Namekata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayuki","family":"Harada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neulet.2016.12.057_bib0005","doi-asserted-by":"crossref","first-page":"7486","DOI":"10.1167\/iovs.14-14792","article-title":"Acetylation preserves retinal ganglion cell structure and function in a chronic model of ocular hypertension","volume":"55","author":"Alsarraf","year":"2014","journal-title":"Invest. Ophthalmol. Visual Sci"},{"key":"10.1016\/j.neulet.2016.12.057_bib0010","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1167\/iovs.09-3903","article-title":"Valproic acid-mediated neuroprotection and regeneration in injured retinal ganglion cells","volume":"51","author":"Biermann","year":"2010","journal-title":"Invest. Ophthalmol. Visual Sci."},{"key":"10.1016\/j.neulet.2016.12.057_bib0015","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1007\/s11064-014-1241-2","article-title":"Valproic Acid: a new candidate of therapeutic application for the acute central nervous system injuries","volume":"39","author":"Chen","year":"2014","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neulet.2016.12.057_bib0020","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1124\/pr.111.005512","article-title":"Therapeutic potential of mood stabilizers lithium and valproic acid: beyond bipolar disorder","volume":"65","author":"Chiu","year":"2013","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neulet.2016.12.057_bib0025","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/ncpneuro0950","article-title":"Optical coherence tomography: a window into the mechanisms of multiple sclerosis","volume":"4","author":"Frohman","year":"2008","journal-title":"Nat. Clin. Pract. Neurol."},{"key":"10.1016\/j.neulet.2016.12.057_bib0030","doi-asserted-by":"crossref","first-page":"6969","DOI":"10.1093\/emboj\/20.24.6969","article-title":"Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells","volume":"20","author":"G\u00f6ttlicher","year":"2001","journal-title":"EMBO J."},{"key":"10.1016\/j.neulet.2016.12.057_bib0035","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1002\/emmm.201000103","article-title":"Regulation of the severity of neuroinflammation and demyelination by TLR-ASK1-p38 pathway","volume":"2","author":"Guo","year":"2010","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.neulet.2016.12.057_bib0040","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.neulet.2015.02.059","article-title":"Brimonidine suppresses loss of retinal neurons and visual function in a murine model of optic neuritis","volume":"592","author":"Guo","year":"2015","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neulet.2016.12.057_bib0045","doi-asserted-by":"crossref","first-page":"6590","DOI":"10.1523\/JNEUROSCI.5747-03.2004","article-title":"Mood stabilizer valproate promotes ERK pathway-dependent cortical neuronal growth and neurogenesis","volume":"24","author":"Hao","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neulet.2016.12.057_bib0050","doi-asserted-by":"crossref","first-page":"261","DOI":"10.2353\/ajpath.2006.050765","article-title":"Role of apoptosis signal-regulating kinase 1 in stress-induced neural cell apoptosis in vivo","volume":"168","author":"Harada","year":"2006","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.neulet.2016.12.057_bib0055","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1586\/17512433.2014.885835","article-title":"Efficacy and mechanism of anticonvulsant drugs in migraine","volume":"7","author":"Hoffmann","year":"2014","journal-title":"Expert Rev. Clin. Pharmacol."},{"key":"10.1016\/j.neulet.2016.12.057_bib0060","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1126\/science.275.5296.90","article-title":"Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK\/JNK and p38 signaling pathways","volume":"275","author":"Ichijo","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.neulet.2016.12.057_bib0065","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/ncpneuro0764","article-title":"Mechanisms of Disease: aquaporin-4 antibodies in neuromyelitis optica","volume":"4","author":"Jarius","year":"2008","journal-title":"Nat. Clin. Pract. Neurol."},{"key":"10.1016\/j.neulet.2016.12.057_bib0070","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/cdd.2012.122","article-title":"Inhibition of ASK1-p38 pathway prevents neural cell death following optic nerve injury","volume":"20","author":"Katome","year":"2013","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.neulet.2016.12.057_bib0075","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.neulet.2014.12.054","article-title":"Valproic acid prevents retinal degeneration in a murine model of normal tension glaucoma","volume":"588","author":"Kimura","year":"2015","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neulet.2016.12.057_bib0080","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.ajpath.2014.11.005","article-title":"Valproic acid prevents NMDA-induced retinal ganglion cell death via stimulation of neuronal TrkB receptor signaling","volume":"185","author":"Kimura","year":"2015","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.neulet.2016.12.057_bib0085","doi-asserted-by":"crossref","first-page":"669","DOI":"10.2165\/00023210-200216100-00003","article-title":"Basic pharmacology of valproate: a review after 35 years of clinical use for the treatment of epilepsy","volume":"16","author":"L\u00f6scher","year":"2002","journal-title":"CNS Drugs"},{"key":"10.1016\/j.neulet.2016.12.057_bib0090","doi-asserted-by":"crossref","first-page":"28656","DOI":"10.1074\/jbc.M112.356584","article-title":"The antiepileptic drug valproic acid restores T cell homeostasis and ameliorates pathogenesis of experimental autoimmune encephalomyelitis","volume":"287","author":"Lv","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neulet.2016.12.057_bib0095","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1007\/s40263-013-0093-7","article-title":"Neuroprotection in multiple sclerosis: a therapeutic approach","volume":"27","author":"Maghzi","year":"2013","journal-title":"CNS Drugs"},{"key":"10.1016\/j.neulet.2016.12.057_bib0100","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1212\/01.wnl.0000303817.82134.da","article-title":"NMO-IgG predicts the outcome of recurrent optic neuritis","volume":"70","author":"Matiello","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.neulet.2016.12.057_bib0105","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1002\/eji.1830250723","article-title":"A myelin oligodendrocyte glycoprotein peptide induces typical chronic experimental autoimmune encephalomyelitis in H-2b mice: fine specificity and T-cell receptor V beta expression of encephalitogenic T cells","volume":"25","author":"Mendel","year":"1995","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.neulet.2016.12.057_bib0110","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S1474-4422(05)70071-5","article-title":"Clinically isolated syndromes suggestive of multiple sclerosis, part I: natural history, pathogenesis, diagnosis, and prognosis","volume":"4","author":"Miller","year":"2005","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neulet.2016.12.057_bib0115","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2174\/1874467210902010095","article-title":"Biochemical, molecular and epigenetic mechanisms of valproic acid neuroprotection","volume":"2","author":"Monti","year":"2009","journal-title":"Curr. Mol. Pharmacol."},{"key":"10.1016\/j.neulet.2016.12.057_bib0120","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1159\/000352021","article-title":"Valproic Acid attenuates disease symptoms and increases endogenous myelin repair by recruiting neural stem cells and oligodendrocyte progenitors in experimental autoimmune encephalomyelitis","volume":"13","author":"Pazhoohan","year":"2014","journal-title":"Neurodegener. Dis."},{"key":"10.1016\/j.neulet.2016.12.057_bib0125","doi-asserted-by":"crossref","first-page":"36734","DOI":"10.1074\/jbc.M101287200","article-title":"Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen","volume":"276","author":"Phiel","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neulet.2016.12.057_bib0130","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.nbd.2007.02.006","article-title":"Valproic acid-mediated neuroprotection in intracerebral hemorrhage via histone deacetylase inhibition and transcriptional activation","volume":"26","author":"Sinn","year":"2007","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neulet.2016.12.057_bib0135","doi-asserted-by":"crossref","first-page":"4344","DOI":"10.2174\/092986711797200408","article-title":"Evaluation of anticonvulsants for possible use in neuropathic pain","volume":"18","author":"Waszkielewicz","year":"2011","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.neulet.2016.12.057_bib0140","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/0006-8993(91)90078-A","article-title":"Valproate suppresses N-methyl-D-aspartate-evoked, transient depolarizations in the rat neocortex in vitro","volume":"544","author":"Zeise","year":"1991","journal-title":"Brain Res."},{"key":"10.1016\/j.neulet.2016.12.057_bib0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2014.01.051","article-title":"Neuroprotective and anti-apoptotic effects of valproic acid on adult rat cerebral cortex through ERK and Akt signaling pathway at acute phase of traumatic brain injury","volume":"1555","author":"Zhang","year":"2014","journal-title":"Brain Res."},{"key":"10.1016\/j.neulet.2016.12.057_bib0150","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.neuroscience.2012.07.013","article-title":"Valproic acid ameliorates inflammation in experimental autoimmune encephalomyelitis rats","volume":"221","author":"Zhang","year":"2012","journal-title":"Neuroscience"},{"key":"10.1016\/j.neulet.2016.12.057_bib0155","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.neuroscience.2012.07.056","article-title":"Valproate promotes survival of retinal ganglion cells in a rat model of optic nerve crush","volume":"224","author":"Zhang","year":"2012","journal-title":"Neuroscience"}],"container-title":["Neuroscience Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394016310059?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394016310059?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,20]],"date-time":"2022-07-20T04:25:43Z","timestamp":1658291143000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304394016310059"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":31,"alternative-id":["S0304394016310059"],"URL":"https:\/\/doi.org\/10.1016\/j.neulet.2016.12.057","relation":{},"ISSN":["0304-3940"],"issn-type":[{"value":"0304-3940","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Valproic acid and ASK1 deficiency ameliorate optic neuritis and neurodegeneration in an animal model of multiple sclerosis","name":"articletitle","label":"Article Title"},{"value":"Neuroscience Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neulet.2016.12.057","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}